ERBB2 and triple-negative breast carcinoma: Among these four subtypes, triple-negative breast cancer (TNBC) is characterized by the loss of expression of human epidermal growth factor receptor 2 (HER2) and hormonal receptors, which accounts for approximately 15% of all breast cancers (Carey et al., 2010).